市场调查报告书
商品编码
1390644
肉毒桿菌毒素市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测Botulinum Toxin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球肉毒桿菌毒素市场规模达54亿美元。展望未来, IMARC Group预计到2028年市场规模将达到84亿美元,2022-2028年复合年增长率(CAGR)为7.64%。
肉毒桿菌毒素是肉毒桿菌产生的神经毒素,肉毒桿菌是一种厌氧、革兰氏阳性、产芽孢桿,常见于植物、土壤、水和动物肠道。它在各种医疗状况的管理中发挥着重要作用。这些病症包括斜视和局部肌张力失调、颜面肌痉挛、头痛、唾液分泌过多、多汗症和痉挛性运动障碍。此外,它也用于治疗对现有药物治疗有部分反应的各种慢性疾病。如今,它也用于暂时减少皱眉纹、皱纹以及脸部、下巴、颈部和胸部皱纹的美容目的。
慢性和急性疾病的盛行率和诊断率显着上升是推动市场成长的关键因素之一。肉毒桿菌毒素广泛应用于治疗皮肤病,例如平滑肌过度活跃、腺体活动异常和多汗症。此外,个人美容意识的不断增强,以及他们接受重建和整容手术的意愿,正在促进市场的成长。此外,美容旅游的兴起,加上社交媒体影响力的不断增强、城市化的快速发展以及人均收入的不断膨胀,正在对市场产生积极的影响。除此之外,随着年龄的增长,皮肤变得更容易出现皱纹和下垂,不断增长的老年人口以及保持年轻健康皮肤的愿望正在推动市场成长。此外,透过组合不同血清型来开发新的强效毒素可以减少总单位和总抗原剂量,并提高有效性和作用持续时间。这些进步预计将为市场创造积极的前景。
The global botulinum toxin market size reached US$ 5.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.64% during 2022-2028.
Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum, which is an anaerobic, gram-positive, spore-forming rod commonly found in plants, soil, water, and intestinal tracts of animals. It plays a significant role in the management of a wide variety of medical conditions. These conditions include strabismus and focal dystonia, hemifacial spasm, headaches, hypersalivation, hyperhidrosis, and spastic movement disorders. Moreover, it is utilized in the treatment of various chronic diseases that respond partially to available medical treatments. Nowadays, it is also used for the cosmetic purpose of temporarily reducing frown lines, creases, and wrinkles on the face, chin, neck, and chest.
A significant rise in the prevalence and diagnosis of chronic and acute diseases represents one of the key factors bolstering the market growth. Botulinum toxin finds extensive applications in the treatment of dermatological conditions, such as overactive smooth muscles, abnormal activity of glands, and hyperhidrosis. Moreover, the rising beauty consciousness among individuals, along with their willingness to undergo reconstructive and cosmetic surgeries, is contributing to market growth. In addition, the emerging trend of cosmetic tourism, in confluence with the increasing influence of social media, rapid urbanization, and inflating per capita income, is influencing the market positively. Apart from this, as the skin becomes more susceptible to wrinkles and sagging with age, the growing geriatric population and the desire to retain young and healthy skin are bolstering the market growth. Furthermore, the development of new potent toxins by combining different serotypes can reduce the total units and overall antigenic dose and improve effectiveness and duration of effect. These advancements are projected to create a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global botulinum toxin market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and end user.
Toxin Type A
Toxin Type B
Therapeutics
Aesthetics
Hospitals and Clinics
Dermatology Clinics
Spas and Cosmetic Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Eisai Co. Ltd, Evolus Inc, Galderma SA, HUGEL Inc., Ipsen Group, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Metabiologics Inc. and Revance Therapeutics Inc.